In clinical practice for hepatic hemangioma the ultrasound description is usually a hyperechoic mass, and in the case of malignant tumors, it is usually described as a hypoechoic mass. For hepatic hemangioma, ultrasound suggests a high-density or hyperechoic mass, further enhanced CT or even enhanced MRI is usually required for clinical diagnosis to distinguish it from malignant tumors such as liver cancer. The exact cause of hepatic hemangioma is not clear so far, and there are no drugs that can control the development of hepatic hemangioma and make it shrink or disappear clinically. The vast majority of hepatic hemangiomas can be free of any clinical symptoms, and most patients can be free of any development of hepatic hemangioma for life. Therefore, the current clinical management of hepatic hemangioma is usually close observation and regular follow-up, that is, review liver ultrasound every 3-6 months to understand whether the mass has increased in size.